Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets

被引:1
|
作者
Vergara, Ismael A. [1 ,2 ,3 ]
Aivazian, Karina [1 ,4 ,5 ]
Carlino, Matteo S. [1 ,6 ,7 ]
Guminski, Alexander D. [1 ,8 ,9 ]
Maher, Nigel G. [1 ,2 ,4 ,5 ]
Shannon, Kerwin F. [1 ,2 ,10 ]
Ch'ng, Sydney [1 ,2 ,10 ]
Saw, Robyn P. M. [1 ,2 ,10 ]
Long, Georgina, V [1 ,2 ,3 ,8 ,9 ]
Wilmott, James S. [1 ,2 ,3 ]
Scolyer, Richard A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[3] Univ Sydney, Charles Perkin Ctr, Sydney, NSW, Australia
[4] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia
[5] NSW Hlth Pathol, Sydney, NSW, Australia
[6] Blacktown Hosp, Dept Med, Blacktown, NSW, Australia
[7] Westmead Hosp, Crown Princess Mary Canc Ctr, Dept Med, Sydney, NSW, Australia
[8] Royal North Shore, Sydney, NSW, Australia
[9] Mater Hosp, Sydney, NSW, Australia
[10] Royal Prince Alfred Hosp, Camperdown, NSW, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
basal cell carcinoma; diagnosis; drivers; genomics; metastasis; pathology; therapeutic targets; treatment; COPY NUMBER; TUMOR; CANCER; PATHWAY; MUTATIONS; G691S; PHOSPHORYLATION; POLYMORPHISM; PROGRESSION; ACTIVATION;
D O I
10.1016/j.modpat.2023.100099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Basal cell carcinomas (BCCs) are human beings' most common malignant tumors. Most are easily managed by surgery or topical therapies, and metastasis is rare. Although BCCs can become locally advanced, metastatic BCCs are very uncommon and may be biologically distinct. We assessed the clinicopathologic characteristics of 17 patients with metastatic BCC and pursued whole-exome sequencing of tumor and germline DNA from 8 patients. Genomic profiling revealed aberrant acti-vation of Hedgehog signaling and alterations in GLI transcriptional regulators and Notch and Hippo signaling. Matched local recurrences of primary BCCs and metastases from 3 patients provided evi-dence of a clonal origin in all cases. Mutations associated with YAP inhibition were found exclusively in 2 hematogenously-spread lung metastases, and metastatic BCCs were enriched for mutations in the YAP/TAZ-binding domain of TEAD genes. Accordingly, YAP/TAZ nuclear localization was associated with metastatic types and Hippo mutations, suggesting an enhanced oncogenic role in hematogenously-spread metastases. Mutations in RET, HGF, and phosphatidylinositol 3-kinase (PI3K)/ protein kinase B (AKT) signaling were enriched compared with a cohort of low clinical-risk BCCs. Our results implicate Hippo and PI3K/AKT dysregulation in metastatic progression of BCCs, making these potential therapeutic targets in metastatic disease. The common clonal origin of matched recurrent and metastatic BCCs suggests that molecular profiling can assist in determining the nature/origin of poorly differentiated metastatic tumors of uncertain type. Genes and pathways enriched for mutations in this cohort are candidate drivers of metastasis and can be used to identify patients at high risk of metastasis who may benefit from aggressive local treatment and careful clinical follow-up.(c) 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Mutational Profiling of Cancer Candidate Genes in Glioblastoma, Melanoma and Pancreatic Carcinoma Reveals a Snapshot of Their Genomic Landscapes
    Bleeker, Fonnet E.
    Lamba, Simona
    Rodolfo, Monica
    Scarpa, Aldo
    Leenstra, Sieger
    Vandertop, W. Peter
    Bardelli, Alberto
    HUMAN MUTATION, 2009, 30 (02) : E451 - E459
  • [22] Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative
    Lim, Sun Min
    Kim, Eun Young
    Kim, Hye Ryun
    Ali, Siraj M.
    Greenbowe, Joel R.
    Shim, Hyo Sup
    Chang, Hyun
    Lim, Seungtaek
    Paik, Soonmyung
    Cho, Byoung Chul
    ONCOTARGET, 2016, 7 (17) : 24172 - 24178
  • [23] Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression
    Marcon, Julian
    DiNatale, Renzo G.
    Sanchez, Alejandro
    Kotecha, Ritesh R.
    Gupta, Sounak
    Kuo, Fengshen
    Makarov, Vladimir
    Sandhu, Amar
    Mano, Roy
    Silagy, Andrew W.
    Blum, Kyle A.
    Nassau, Daniel E.
    Benfante, Nicole E.
    Ortiz, Michael, V
    Carlo, Maria, I
    Chan, Timothy A.
    Motzer, Robert J.
    Voss, Martin H.
    Coleman, Jonathan
    Russo, Paul
    Reuter, Victor
    Hakimi, A. Ari
    Reznik, Ed
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3629 - 3640
  • [24] Evolving therapeutic targets in renal cell carcinoma
    Singer, Eric A.
    Gupta, Gopal N.
    Marchalik, Daniel
    Srinivasan, Ramaprasad
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 273 - 280
  • [25] A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy
    Buetti-Dinh, Antoine
    Jensen, Rebecca
    Friedman, Ran
    BMC CANCER, 2018, 18
  • [26] Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV plus Versus HPV- Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets
    Williams, Erik A.
    Werth, Adrienne J.
    Sharaf, Radwa
    Montesion, Meagan
    Sokol, Ethan S.
    Pavlick, Dean C.
    McLaughlin-Drubin, Molly
    Erlich, Rachel
    Toma, Helen
    Williams, Kevin Jon
    Venstrom, Jeff M.
    Alexander, Brian M.
    Shah, Nikunj
    Danziger, Natalie
    Hemmerich, Amanda C.
    Severson, Eric A.
    Killian, Jonathan Keith
    Lin, Douglas I.
    Ross, Jeffrey S.
    Tse, Julie Y.
    Ramkissoon, Shakti H.
    Mochel, Mark C.
    Elvin, Julia A.
    JCO PRECISION ONCOLOGY, 2020, 4 : 647 - 661
  • [27] Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome
    Ali, O. Hasan
    Yurchenko, A. A.
    Pavlova, O.
    Sartori, A.
    Bomze, D.
    Higgins, R.
    Ring, S. S.
    Hartmann, F.
    Buehler, D.
    Fritzsche, F. R.
    Jochum, W.
    Navarini, A. A.
    Kim, A.
    French, L. E.
    Dermitzakis, E.
    Christiano, A. M.
    Hohl, D.
    Bickers, D. R.
    Nikolaev, S., I
    Flatz, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (02) : 396 - 402
  • [28] Metastatic Basal Cell Carcinoma Presenting as a Neck Mass
    Kahveci, Orhan Kemal
    Okur, Erdogan
    Sahin, Onder
    Altuntas, Ali
    Okur, Nazan
    Aktepe, Fatma
    JOURNAL OF CRANIOFACIAL SURGERY, 2010, 21 (02) : 592 - 594
  • [29] Pretibial metastatic basal cell carcinoma
    Cantwell, Phillip
    MEDICAL JOURNAL OF AUSTRALIA, 2020, 212 (03)
  • [30] The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy
    van der Mijn, Johannes C.
    Eng, Kenneth W.
    Chandra, Pooja
    Fernandez, Evan
    Ramazanoglu, Sinan
    Sigaras, Alexandros
    Oromendia, Clara
    Gudas, Lorraine J.
    Tagawa, Scott T.
    Nanus, David M.
    Faltas, Bishoy F.
    Beltran, Himisha
    Sternberg, Cora N.
    Elemento, Olivier
    Sboner, Andrea
    Mosquera, Juan Miguel
    Molina, Ana M.
    MOLECULAR ONCOLOGY, 2022, 16 (12) : 2384 - 2395